Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Integra Neurosciences — Predicate Candidate Screening

8 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

51 daysmedian FDA review time
87 days90th percentile
8clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K082250AURAGEN CORTICAL SURFACE ELECTRODESIntegra Neurosciences2008-10-10630
K050720NEUROSENSOR CEREBRAL BLOOD FLOW AND INTRACRANIAL PRESSURE MOIntegra Neurosciences2005-05-11511
K031086CAMINO SINGLE PARAMETER MONITOR, MODEL SPM-1Integra Neurosciences2003-05-14370
K021989SELECTOR INTEGRA ULTRASONIC SURGICAL ASPIRATOR, MODEL OM 153Integra Neurosciences2002-09-13872
K022554MONITORR ICP EXTERNAL CSF DRAINAGE AND MONITORING SYSTEMIntegra Neurosciences2002-08-23212
K022553CAMINO INTRACRANIAL PRESSURE MONITORING CATHETER WITH LICOX Integra Neurosciences2002-08-20180
K020558LICOX CC1.G2 BRAIN OXYGEN CATHETER-MICROPROBEIntegra Neurosciences2002-03-21290
K002765LICOX CMP MONITOR-AC3.1, LICOX IMC OXYGEN CATHETERS-CC1,CC1.Integra Neurosciences2000-11-24803

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda